Riskpilot← Back to searchSign inGet full accessNuclea AB
ABActiveOrg 5569608432Metallvägen 3 AHospital activities · NACE 8610Est. 20142 employees
Revenue 2024
SEK 2M
-49% vs 2023
EBITDA margin
-0.4%
-101% vs 2023
Equity ratio
96.4%
Financial strength
Net profit 2024
SEK -1,6M
-236% vs 2023
| Revenue | SEK 2M | -49% |
| EBITDA | SEK -9K | -101% |
| Net profit | SEK -1,6M | -236% |
| Total assets | SEK 5,3M | -27% |
| Equity | SEK 5,1M | -26% |
| Employees | 2 | — |
Legal name
Nuclea AB
Org number
5569608432
Legal form
Aktiebolag
NACE code
8610 · Hospital activities
Founded
4 februari 2014
Share capital
SEK 50 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Läkarverksamhet, konsultverksamhet inom hälso-sjukvård samt därmed förenlig verksamhet. Metallbearbetning och mekanisk verkstad, verkstadsmaskinservice (tryckluft- och eldrivna dito). Medicinsk Fotvård
Address
Metallvägen 3 A
Email
marie.e.frolander@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | 2 329 | 3 248 | 2 572 | 2 814 | 3 082 | 3 868 | 1 985 |
| Staff expenses | — | — | — | — | — | — | −1 479 | −1 610 | −1 472 |
| EBITDA | 432 | 2 459 | 1 053 | 1 698 | 1 310 | 1 479 | 1 065 | 1 406 | −9 |
| Depreciation & amort. | −0 | −0 | −8 | −25 | −23 | −0 | −35 | −46 | −50 |
| EBIT | 432 | 2 459 | 1 045 | 1 673 | 1 287 | 1 479 | 1 030 | 1 360 | −58 |
| Net financials | 99 | 74 | −930 | 85 | 53 | 77 | 37 | 123 | −1 576 |
| Profit before tax | 530 | 2 534 | 433 | 1 757 | 1 371 | 1 556 | 1 067 | 1 484 | −1 635 |
| Tax | −215 | −337 | −238 | −364 | −285 | −309 | −221 | −281 | — |
| Net profit | 315 | 2 197 | 195 | 1 393 | 1 086 | 1 247 | 845 | 1 202 | −1 635 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | 2 297 | 2 746 | 2 719 | 4 248 | 4 874 | 5 868 | 6 448 | 7 264 | 5 290 |
| Equity | 752 | 2 589 | 2 584 | 3 727 | 4 613 | 5 611 | 6 096 | 6 886 | 5 101 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | — | — | — |
| Short-term debt | 283 | 157 | 106 | 490 | 260 | 257 | 352 | 379 | 189 |
| Total debt | 283 | 157 | 106 | 490 | 260 | 257 | 352 | 379 | 189 |
EBITDA margin
-0.4%
This company
15.8%
Market median
-103% vs market
20162024
Equity ratio
96.4%
This company
38.2%
Market median
+152% vs market
20162024
Return on equity
-32.1%
This company
18.4%
Market median
-274% vs market
20162024
Net profit margin
-82.4%
This company
8.1%
Market median
-1117% vs market
20162024
Asset turnover
0.38×
This company
1.12×
Market median
-66% vs market
20162024
Debt / equity
0.04×
This company
0.62×
Market median
+94% vs market
20162024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
AT Audit | Audit | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2022 | — | — | |
| Deputy Board Member | 2022 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Nuclea AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Angelika Thor | Audit | 0 companies |
| Per Stefan Frölander | Board of Directors | 0 companies |
| Marie Elisabeth Frölander | Deputy Board Member | 0 companies |